Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1(S)-4,5-dihydro-2-[2-hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazo----1件: 284 💬
2(S)-4,5-dihydro-2-[2-hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazolecarboxylate magnesium hydroxide2件: Magnesium,
Magnesium hydroxide		1件: Magnesium hydroxide 💬 --1件: 284 💬
3(S)-4,5-dihydro-2[hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-m----1件: 284 💬
4(S)-4,5-dihydro-2[hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazolecarboxylate magnesium hydroxide2件: Magnesium,
Magnesium hydroxide		1件: Magnesium hydroxide 💬 --1件: 284 💬
5Abatacept1件: Abatacept1件: Abatacept 💬 2件: CD80,
CD86 💬 		14件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬28件: 2, 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬
6Alefacept1件: Alefacept1件: Alefacept 💬 1件: CD58 💬 2件: Cell adhesion molecule (CAM) interaction, Epstein-Barr virus infection 💬6件: 37, 60, 65, 164, 284, 285 💬
7ALEMTUZUMAB1件: Alemtuzumab1件: Alemtuzumab 💬 --21件: 13, 14, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 107, 164, 283, 284, 285, 326 💬
8Allogeneic Bone Marrow Transplantation----8件: 60, 62, 65, 96, 164, 284, 285, 286 💬
9Allogeneic hematopoietic stem cell transplantation----8件: 28, 51, 60, 62, 65, 164, 284, 285 💬
10Alpha beta depletion----2件: 60, 284 💬
11Anti-Thymocyte Globulin----19件: 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 63, 65, 164, 283, 284, 285 💬
12Antithymocyte Globulin----3件: 60, 65, 284 💬
13APR-20201件: APR-2020---1件: 284 💬
14Biospecimen Collection----18件: 13, 26, 28, 34, 46, 49, 50, 51, 53, 60, 62, 65, 96, 97, 159, 284, 285, 286 💬
15Bitopertin1件: Bitopertin1件: Bitopertin 💬 1件: SLC6A9 💬 2件: Neuroactive ligand signaling, Synaptic vesicle cycle 💬2件: 254, 284 💬
16Bone Marrow Aspiration----7件: 28, 60, 62, 65, 284, 285, 286 💬
17Bone Marrow Biopsy----7件: 26, 28, 60, 62, 65, 284, 286 💬
18Bone marrow transplantation----4件: 51, 60, 284, 285 💬
19BPX-501 T cells----4件: 65, 284, 285, 326 💬
20Busulfan1件: Busulfan1件: Busulfan 💬 --14件: 19, 20, 28, 34, 36, 49, 51, 60, 65, 164, 274, 284, 285, 326 💬
21Busulfan, Cyclophosphamide, ATG, GCSF2件: Busulfan,
Cyclophosphamide		3件: Busulfan ,
Cyclophosphamide ,
Cyclophosphamide 💬 		--2件: 65, 284 💬
22Busulfan, Fludarabine, ATG, TLI2件: Busulfan,
Fludarabine		3件: Busulfan ,
Fludarabine phosphate ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 65, 284 💬
23Campath, Fludarabine, Cyclophosphamide2件: Cyclophosphamide,
Fludarabine		4件: Cyclophosphamide ,
Fludarabine phosphate ,
Cyclophosphamide ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 65, 284 💬
24CD3/CD19 depleted leukocytes----1件: 284 💬
25CD34 Stem Cell Selection Therapy----3件: 60, 65, 284 💬
26CD45RA depleted leukocytes----1件: 284 💬
27Computed Tomography----13件: 26, 28, 34, 40, 46, 49, 60, 62, 65, 96, 284, 285, 286 💬
28Cyclophosphamide1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--50件: 11, 13, 14, 16, 19, 20, 26, 28, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 62, 63, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 223, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
29Cyclophosphamide Dose Level 11件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--2件: 65, 284 💬
30Cyclophosphamide Dose Level 21件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--2件: 65, 284 💬
31Cyclophosphamide Dose Level 31件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--2件: 65, 284 💬
32Cyclophosphamide Dose Level 41件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--2件: 65, 284 💬
33Cyclosporine1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬39件: 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
34DACLIZUMAB1件: Daclizumab1件: Daclizumab 💬 1件: IL2RA 💬 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬10件: 13, 26, 56, 60, 63, 65, 97, 107, 283, 284 💬
35Deferasirox1件: Deferasirox1件: Deferasirox 💬 --5件: 54, 60, 254, 284, 286 💬
36Deferitazole1件: Deferitazole1件: Deferitazole 💬 --1件: 284 💬
37Deferoxamine1件: Deferoxamine3件: Deferoxamine mesylate ,
Deferoxamine ,
Deferoxamine hydrochloride 💬 		--2件: 284, 286 💬
38Desferal----2件: 284, 286 💬
39DFO----2件: 284, 286 💬
40Echocardiography----6件: 28, 60, 62, 65, 284, 286 💬
41ELTROMBOPAG1件: Eltrombopag2件: Eltrombopag olamine ,
Eltrombopag choline 💬 		1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬5件: 60, 63, 65, 284, 285 💬
42Enriched Hematopoetic Stem Cell Infusion----2件: 19, 284 💬
43Exjade----3件: 254, 284, 286 💬
44FBS0701----1件: 284 💬
45FBS0701 CAPSULE----1件: 284 💬
46FBS0701/SSP004184----1件: 284 💬
47Filgrastim1件: Filgrastim1件: Filgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬30件: 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 63, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
48Fludarabine1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬30件: 11, 13, 14, 16, 19, 28, 34, 35, 36, 44, 46, 49, 50, 51, 60, 61, 62, 63, 65, 85, 96, 107, 164, 222, 223, 283, 284, 285, 286, 326 💬
49Fludarabine monophosphate1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬3件: 65, 284, 326 💬
50Fludarabine phosphate1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬14件: 28, 36, 49, 51, 60, 61, 62, 63, 65, 96, 283, 284, 285, 286 💬
51G-CSF1件: Filgrastim1件: Filgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬12件: 6, 11, 13, 51, 60, 61, 63, 65, 85, 96, 284, 285 💬
52Human Placental Derived Stem Cell----4件: 19, 20, 60, 284 💬
53Hydroxyurea1件: Hydroxyurea1件: Hydroxyurea 💬 1件: RRM2 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway 💬10件: 3, 13, 19, 20, 46, 65, 85, 86, 107, 284 💬
54ICL670----3件: 60, 284, 286 💬
55Iron1件: Iron1件: Ferrous fumarate 💬 --7件: 18, 60, 96, 97, 238, 254, 284 💬
56IRON CHELATING AGENTS1件: Iron1件: Ferrous fumarate 💬 --1件: 284 💬
57L-leucine1件: Leucine1件: Leucine 💬 --1件: 284 💬
58Lapine T-Lymphocyte Immune Globulin----4件: 62, 65, 284, 286 💬
59Lenalidomide1件: Lenalidomide1件: Lenalidomide 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
60Leucine1件: Leucine1件: Leucine 💬 --13件: 5, 6, 7, 18, 19, 65, 96, 97, 127, 280, 283, 284, 299 💬
61Leukapheresis----6件: 49, 51, 85, 96, 284, 285 💬
62Magnesium1件: Magnesium---23件: 3, 6, 11, 13, 15, 46, 64, 70, 71, 93, 97, 113, 166, 225, 234, 235, 256, 284, 291, 296, 297, 298, 340 💬
63Magnesium hydroxide2件: Magnesium,
Magnesium hydroxide		1件: Magnesium hydroxide 💬 --1件: 284 💬
64Melphalan1件: Melphalan2件: Melphalan ,
Melphalan hydrochloride 💬 		--19件: 11, 13, 14, 19, 20, 28, 34, 46, 60, 62, 65, 96, 107, 164, 222, 234, 284, 285, 299 💬
65Mesenchymal stromal cells----7件: 36, 51, 96, 97, 107, 274, 284 💬
66Methotrexate1件: Methotrexate2件: Methotrexate ,
Methotrexate sodium 💬 		2件: DHFR,
DHFR2 💬 		3件: Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬41件: 11, 13, 14, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 223, 240, 256, 270, 271, 284, 285, 286, 326, 331 💬
67Methylprednisolone1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬51件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
68Mobilization Regimen----2件: 2, 284 💬
69Multigated Acquisition Scan----5件: 60, 62, 65, 284, 286 💬
70Mycophenolate mofetil2件: Mycophenolate mofetil,
Mycophenolic acid		4件: Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride ,
Mycophenolate sodium ,
Mycophenolic acid 💬 		2件: IMPDH1,
IMPDH2 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬38件: 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 57, 60, 61, 62, 63, 65, 66, 93, 95, 96, 118, 162, 164, 222, 223, 224, 226, 234, 283, 284, 285, 300 💬
71Myeloablative Preparative Regimen----3件: 62, 65, 284 💬
72Other: Laboratory Biomarker Analysis----22件: 11, 13, 14, 26, 28, 34, 40, 49, 51, 60, 62, 65, 89, 96, 97, 205, 232, 283, 284, 285, 298, 331 💬
73Other: Quality-of-Life Assessment----9件: 34, 36, 51, 62, 65, 96, 284, 286, 298 💬
74Peripheral Blood Stem Cell Transplantation----12件: 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285, 286 💬
75Prednisone1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬58件: 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 127, 145, 162, 164, 205, 222, 223, 224, 228, 251, 269, 283, 284, 285, 288, 299, 300, 303, 307, 331 💬
76Radiation therapy----3件: 13, 284, 285 💬
77Radiation: radiation therapy----5件: 34, 60, 65, 284, 285 💬
78Radiation: Total Body Irradiation----11件: 19, 36, 49, 51, 60, 62, 65, 96, 222, 283, 284 💬
79Radiation: total-body irradiation----9件: 28, 51, 60, 62, 65, 96, 283, 284, 285 💬
80Reduced Intensity Preparative Regimen----3件: 62, 65, 284 💬
81Reduced Toxicity Ablative Regimen----3件: 62, 65, 284 💬
82Rimiducid1件: Rimiducid1件: Rimiducid 💬 1件: CASP9 💬 34件: Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Colorectal cancer, Endometrial cancer, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Huntington disease, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Measles, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parkinson disease, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Prostate cancer, Small cell lung cancer, Thyroid hormone signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Viral myocarditis, p53 signaling pathway 💬7件: 19, 49, 60, 65, 284, 285, 326 💬
83RITUXIMAB1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬54件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
84Rivogenlecleucel1件: Rivogenlecleucel1件: Rivogenlecleucel 💬 --6件: 19, 60, 65, 284, 285, 326 💬
85SOTATERCEPT1件: Sotatercept1件: Sotatercept 💬 1件: ACVR2A 💬 4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬2件: 86, 284 💬
86Sotatercept with prednisone boost2件: Prednisone,
Sotatercept		2件: Prednisone ,
Sotatercept 💬 		2件: ACVR2A,
NR3C1 💬 		5件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Neuroactive ligand-receptor interaction, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬1件: 284 💬
87SSP-004184 100 mg----1件: 284 💬
88SSP-004184 100 mg Capsule----1件: 284 💬
89SSP-004184 250 mg----1件: 284 💬
90SSP-004184 250 mg Capsule----1件: 284 💬
91SSP-004184 375 mg----1件: 284 💬
92SSP-004184 375 mg Capsule----1件: 284 💬
93SSP-004184 50 mg----1件: 284 💬
94SSP-004184 50 mg Capsule----1件: 284 💬
95SSP-004184 500 mg----1件: 284 💬
96SSP-004184 500 mg Capsule----1件: 284 💬
97SSP-004184AQ 100 mg----1件: 284 💬
98SSP-004184AQ 100 mg Capsule----1件: 284 💬
99SSP-004184AQ 200 mg----1件: 284 💬
100SSP-004184AQ 200 mg Capsule----1件: 284 💬
101SSP-004184AQ 250 mg----1件: 284 💬
102SSP-004184AQ 250 mg Capsule----1件: 284 💬
103SSP-004184AQ 375 mg----1件: 284 💬
104SSP-004184AQ 375 mg Capsule----1件: 284 💬
105SSP-004184AQ 50 mg----1件: 284 💬
106SSP-004184AQ 50 mg Capsule----1件: 284 💬
107Stem Cell Infusion----4件: 28, 60, 65, 284 💬
108Stem Cell Transplant----6件: 19, 20, 60, 65, 164, 284 💬
109Tacrolimus1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬37件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 57, 60, 61, 62, 63, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 223, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬
110Thiotepa1件: Thiotepa1件: Thiotepa 💬 --14件: 13, 19, 20, 28, 46, 51, 60, 65, 85, 96, 107, 164, 284, 285 💬
111Thiotepa--escalated dose1件: Thiotepa1件: Thiotepa 💬 --4件: 19, 20, 65, 284 💬
112Thiotepa--single daily dose1件: Thiotepa1件: Thiotepa 💬 --4件: 19, 20, 65, 284 💬
113Total lymphoid irradiation----3件: 65, 284, 326 💬
114TREOSULFAN1件: Treosulfan1件: Treosulfan 💬 --6件: 13, 19, 62, 65, 284, 286 💬
115Trifluoperazine1件: Trifluoperazine2件: Trifluoperazine hydrochloride ,
Trifluoperazine 💬 		1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬2件: 283, 284 💬
116Umbilical Cord Blood Transplantation----5件: 60, 65, 284, 285, 326 💬
117X-Ray Imaging----5件: 28, 62, 65, 284, 286 💬